Serial pulmonary function in systemic sclerosis
Reference (28)
- et al.
Pulmonary scleroderma
Dis Chest
(1968) - et al.
Pathologic observations in systemic sclerosis (scleroderma)
Am J Med
(1969) Pulmonary vascular lesions in systemic scleroderma
Dis Chest
(1963)- et al.
Pulmonary vascular changes in scleroderma
Am J Med
(1978) - et al.
An early pulmonary physiologic abnormality in progressive systemic sclerosis (diffuse scleroderma)
Am J Med
(1964) - et al.
Rapid onset of lung involvement in progressive systemic sclerosis
Chest
(1979) - et al.
Small airways in progressive systemic sclerosis (PSS)
Am J Med
(1979) Progressive systemic sclerosis (scleroderma)
- et al.
Survival with systemic sclerosis
Ann Intern Med
(1971) - et al.
Survival in systemic sclerosis (scleroderma)
Arthritis Rheum
(1980)
The lung in scleroderma
The pathophysiology of scleroderma involving the heart and respiratory system
Ann Intern Med
Pulmonary manifestations of progressive systemic sclerosis
Am J Med Sci
Pulmonary function in scleroderma
Arthritis Rheum
Cited by (68)
Association between cigarette smoking and impaired clinical symptoms in systemic sclerosis: A review
2017, Cellular ImmunologyCitation Excerpt :Greenwald et al. [28] demonstrated that nonsmokers had greater rates of decline in total lung capacity and static lung compliance than did current and former smokers. Some other authors have also reported that pulmonary function in nonsmokers was not different and that it did not change at rates different from those in a nonsmoking reference population [29]. This means that individual variability in the course of pulmonary function is large and not completely explained by smoking status.
Connective Tissue Diseases
2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth EditionResting and exercise physiology in interstitial lung diseases
2004, Clinics in Chest MedicineNatural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being
2003, Rheumatic Disease Clinics of North AmericaPulmonary function tests in interstitial lung disease: What role do they have?
2001, Clinics in Chest MedicineCitation Excerpt :In contrast, Bagg and Hughes20 noted gradual progression of restrictive abnormality. A similar gradual progression was reported by Schneider et al,290 who performed serial PFTs in 38 patients followed over a mean of 63 months. The overall trend was of a slowly progressive restrictive defect; the mean rate of loss in FVC was more than three times the normal rate of FVC loss.
Pulmonary-renal syndrome in systemic sclerosis
2001, Seminars in Arthritis and Rheumatism
This study was supported in part by an Arthritis Foundation Clinical Research Center Grant and the Johns Hopkins Multipurpose Arthritis Center Grant 2-P60-AM20588.
- 1
From the Divisions of Rheumatology and Respiratory Medicine, Department of Medicine, Johns Hopkins University School of Medicine at the Good Samaritan Hospital, Baltimore, Maryland.